微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | 36.35% | 3.93% | -2.05% | 99/141 | 52.4% | 佰仁医疗 | 88.71% | 行业排名> |
| 2026-03-31 | 37.11% | 7.19% | 3.01% | 98/141 | 52.37% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-12-31 | 36.02% | 1.96% | 1.47% | 98/141 | 51.9% | 佰仁医疗 | 89.18% | 行业排名> |
| 2025-09-30 | 35.5% | 1.34% | 1.51% | 100/141 | 52.23% | 佰仁医疗 | 88.17% | 行业排名> |
| 2025-06-30 | 34.97% | -0.34% | 1.02% | 104/141 | 52.48% | 佰仁医疗 | 88.54% | 行业排名> |
| 2025-03-31 | 34.62% | -0.52% | -2.01% | 101/141 | 52.13% | 佰仁医疗 | 85.72% | 行业排名> |
| 2024-12-31 | 35.33% | 1.27% | 0.85% | 104/141 | 53.08% | 佰仁医疗 | 88.34% | 行业排名> |
| 2024-09-30 | 35.03% | 1.83% | -0.18% | 102/141 | 53.87% | 佰仁医疗 | 88.56% | 行业排名> |
| 2024-06-30 | 35.09% | 4.44% | 0.84% | 108/141 | 53.95% | 佰仁医疗 | 89.27% | 行业排名> |
| 2024-03-31 | 34.8% | 4.63% | -0.25% | 101/141 | 53.88% | 佰仁医疗 | 89.28% | 行业排名> |
| 2023-12-31 | 34.89% | 3.82% | 1.42% | 106/141 | 53.57% | 正海生物 | 89.9% | 行业排名> |
| 2023-09-30 | 34.4% | -0.4% | 2.38% | 101/141 | 54.44% | 正海生物 | 90.39% | 行业排名> |
| 2023-06-30 | 33.6% | -6.43% | 1.03% | 107/141 | 53.81% | 正海生物 | 90.3% | 行业排名> |
| 2023-03-31 | 33.26% | -6.98% | -1.03% | 103/141 | 54.06% | 万泰生物 | 91.61% | 行业排名> |
| 2022-12-31 | 33.61% | -2.22% | -2.7% | 111/141 | 54.01% | 三友医疗 | 90.18% | 行业排名> |
| 2022-09-30 | 34.54% | 0.78% | -3.82% | 99/141 | 55.7% | 三友医疗 | 90.14% | 行业排名> |
| 2022-06-30 | 35.91% | 3.51% | 0.43% | 103/141 | 55.37% | 三友医疗 | 90.29% | 行业排名> |
| 2022-03-31 | 35.76% | 9.45% | 4.04% | 93/141 | 56.89% | 三友医疗 | 90.73% | 行业排名> |
| 2021-12-31 | 34.37% | 6.13% | 0.28% | 113/141 | 57.98% | 三友医疗 | 90.5% | 行业排名> |
| 2021-09-30 | 34.27% | -8.25% | -1.21% | 98/141 | 59.77% | 三友医疗 | 90.29% | 行业排名> |
| 2021-06-30 | 34.69% | -6.39% | 6.19% | 105/141 | 59.05% | 正海生物 | 90.78% | 行业排名> |
| 2021-03-31 | 32.67% | -6.86% | 0.89% | 89/141 | 61.5% | 正海生物 | 91.59% | 行业排名> |
| 2020-12-31 | 32.38% | -5.86% | -13.31% | 117/141 | 60.12% | 正海生物 | 92.23% | 行业排名> |
| 2020-09-30 | 37.35% | 11.75% | 0.79% | 80/141 | 62.21% | 正海生物 | 92.69% | 行业排名> |
| 2020-06-30 | 37.06% | 19.11% | 5.66% | 97/141 | 60.36% | 正海生物 | 92.61% | 行业排名> |
| 2020-03-31 | 35.08% | 30.47% | 1.97% | 66/141 | 58.8% | 正海生物 | 94.38% | 行业排名> |
| 2019-12-31 | 34.4% | 14.82% | 2.91% | 99/141 | 56.96% | 正海生物 | 93.12% | 行业排名> |
| 2019-09-30 | 33.43% | 13.98% | 7.43% | 54/141 | 55.83% | 正海生物 | 93.78% | 行业排名> |
| 2019-06-30 | 31.12% | 7.92% | 15.74% | 65/141 | 57.93% | 正海生物 | 93.09% | 行业排名> |
| 2019-03-31 | 26.88% | -7.23% | -10.26% | 51/141 | 52.61% | 正海生物 | 93.85% | 行业排名> |
| 2018-12-31 | 29.96% | -2.99% | 2.15% | 102/141 | 56.22% | 正海生物 | 93.08% | 行业排名> |
| 2018-09-30 | 29.33% | -5.5% | 1.72% | 47/141 | 52.76% | 正海生物 | 92.83% | 行业排名> |
| 2018-06-30 | 28.83% | -6.43% | -0.5% | 52/141 | 53.06% | 正海生物 | 92.44% | 行业排名> |
| 2018-03-31 | 28.98% | -3.65% | -6.17% | 44/141 | 52.55% | 正海生物 | 92.7% | 行业排名> |
| 2017-12-31 | 30.88% | -7.51% | -0.49% | 92/141 | 56.1% | 正海生物 | 93.67% | 行业排名> |
| 2017-09-30 | 31.03% | -7.55% | 0.71% | 42/141 | 53.53% | 正海生物 | 94.14% | 行业排名> |
| 2017-06-30 | 30.81% | -7.47% | 2.45% | 51/141 | 54.85% | 正海生物 | 93.83% | 行业排名> |
| 2017-03-31 | 30.08% | -10.57% | -9.93% | 40/141 | 54.29% | 正海生物 | 93.69% | 行业排名> |
| 2016-12-31 | 33.39% | -3.96% | -0.53% | 67/141 | 57.35% | 正海生物 | 92.79% | 行业排名> |
| 2016-09-30 | 33.57% | -3.03% | 0.8% | 33/141 | 51.85% | 健帆生物 | 84.23% | 行业排名> |
| 2016-06-30 | 33.3% | -4.65% | -0.98% | 41/141 | 52.6% | *ST明德 | 86.71% | 行业排名> |
| 2016-03-31 | 33.63% | 2% | -3.26% | 30/141 | 50.24% | 健帆生物 | 83.86% | 行业排名> |